Time: 8 a.m. – 9 a.m. (PST) / 18:00 - 19:00 (MSK)
Topic: Global Approaches in Multiple Myeloma

This program will be moderated by Professor Mustafa Çetiner, MD.

The panel includes the following presenters and topics:

Maxim Solovyev, PhD, Head of Dept. of High Dose Chemotherapy of Paraproteinemic Hemoblastosis, Scientific Medical Research Center of Hematology, Moscow
The Role and Place of Auto-HSCT in MM Treatment (15 min)

Vadim V. Ptushkin, PhD, Professor, Moscow Head Hematologist, Vice-head in Hematology of Moscow Hematological Centre, S.I. Botkin Moscow City Clinical Hospital
Update on Current Therapies of Multiple Myeloma (15 min)

Brian G.M. Durie, MD, Chairman of the International Myeloma Foundation (IMF) and the International Myeloma Working Group (IMWG), Medical Director for AMyC and Specialist in Multiple Myeloma and Related Disorders for Cedars-Sinai Outpatient Cancer Center in Los Angeles
Novel Therapies in Multiple Myeloma Treatment (15 min)

At the end of the webinar, participants will be able to take part in a question & answer session with the panel.

Learn more about current trends in myeloma treatment and research with this update from two major medical meetings held virtually in May and June 2020.

Dr. Brian G.M. Durie will explain what’s new and exciting from:

• American Society of Clinical Oncology (ASCO) Virtual Scientific Program - May 29-31, 2020
• European Hematology Association (EHA) Virtual Congress - June 11-14, 2020

You won’t want to miss this free IMF webinar featuring our panel of top myeloma experts! 

Save the date, register now!

Dr. Brian G.M. Durie discusses key takeaways from the annual conference and explains how this new and important information relates to myeloma patients, caregivers, and other members of the myeloma community.

Thursday January 9, 2020
4:00 pm Pacific/5:00 pm Mountain
6:00 pm Central/7:00 pm Eastern

Click here to view teleconference

Patients, caregivers, and doctors around the world can view the IMF's popular livestream IMWG Conference Series, "Making Sense of Treatment" from Orlando, FL. IMF Chairman Dr. Brian G.M. Durie, Dr. Maria V. Mateos, and IMF Chief Medical Officer Dr. Joseph Mikhael distill, debate, and discuss the latest news and trends in the treatment of multiple myeloma from the 61st Annual ASH Meeting. 

Watch the LIVESTREAM:

Monday December 9, 2019
5:30 PM PT/7:30 PM CT/8:30 PM ET

Click here to view the teleconference

Join us for this year’s International Myeloma Foundation and Clinical Care Options cosponsored symposium, where an esteemed panel of international experts will offer their perspectives on practice-changing data and optimal management of patients with myeloma.

Friday, December 6, 2019
1:00 PM ET/2:00 PM CT/4:00 PM PT

Click here to view the teleconference

Learn more about current trends in myeloma treatment and research with this update from three major medical meetings held in May and June 2019.

Dr. Brian G.M. Durie will explain what’s new and exciting from: 

• American Society of Clinical Oncology (ASCO),
• European Hematology Association (EHA), and 
• International Myeloma Working Group Summit (IMWG).

You won’t want to miss this free IMF teleconference followed by a Q&A session! Save the date, register now!

Register Now

Dr. Brian G.M. Durie will focus on early disease management including criteria for diagnosis and best treatment options. Patients are increasingly diagnosed early and must be certain if decisive first therapy is appropriate or if observation is recommended. With the introduction of new therapies, there are many options to be reviewed and considered for patients in each risk group, including assessment for age and comorbidities. Current best treatment guidelines will be presented.

DOWNLOAD SLIDES

Participant Dial In:
1-866-394-2570
Conference ID:
4572214

4:00 pm Pacific / 5:00 pm Mountain
6:00 pm Central / 7:00 pm Eastern